CH631448A5 - Verfahren zur herstellung neuer piperazinderivate. - Google Patents

Verfahren zur herstellung neuer piperazinderivate. Download PDF

Info

Publication number
CH631448A5
CH631448A5 CH132077A CH132077A CH631448A5 CH 631448 A5 CH631448 A5 CH 631448A5 CH 132077 A CH132077 A CH 132077A CH 132077 A CH132077 A CH 132077A CH 631448 A5 CH631448 A5 CH 631448A5
Authority
CH
Switzerland
Prior art keywords
methyl
methanol
dimethoxybenzyl
radical
piperazine
Prior art date
Application number
CH132077A
Other languages
German (de)
English (en)
Inventor
Richard Dr Cyrus
Manfred Dr Raschack
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of CH631448A5 publication Critical patent/CH631448A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
CH132077A 1976-02-07 1977-02-03 Verfahren zur herstellung neuer piperazinderivate. CH631448A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
CH631448A5 true CH631448A5 (de) 1982-08-13

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
CH132077A CH631448A5 (de) 1976-02-07 1977-02-03 Verfahren zur herstellung neuer piperazinderivate.

Country Status (25)

Country Link
US (1) US4079137A (sv)
JP (1) JPS52105186A (sv)
AT (1) AT355578B (sv)
AU (1) AU504526B2 (sv)
BE (1) BE850492A (sv)
CA (1) CA1094560A (sv)
CH (1) CH631448A5 (sv)
CS (1) CS201544B2 (sv)
DD (1) DD128133A5 (sv)
DE (1) DE2604845A1 (sv)
DK (1) DK138891C (sv)
ES (1) ES455691A1 (sv)
FI (1) FI63226C (sv)
FR (1) FR2340311A1 (sv)
GB (1) GB1550545A (sv)
HU (1) HU173483B (sv)
IE (1) IE44339B1 (sv)
IL (1) IL51316A (sv)
LU (1) LU76706A1 (sv)
NL (1) NL7700841A (sv)
NO (1) NO142625C (sv)
PL (1) PL105526B1 (sv)
PT (1) PT66154B (sv)
SE (1) SE7701187L (sv)
ZA (1) ZA77248B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
AU2005314271B2 (en) 2004-12-06 2011-06-16 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as cancer vaccine adjuvants
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
EP2240195A4 (en) * 2007-12-12 2011-12-21 Sciclone Pharmaceuticals Inc TREATMENT OF MELANOMA WITH ALPHA-THYMOSIN PEPTIDES IN ASSOCIATION WITH ANTIBODIES AGAINST ANTIGEN 4 ASSOCIATED WITH CYTOTOXIC LYMPHOCYTE T (CTLA4)
CA2708229A1 (en) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
EP2230908A1 (en) * 2007-12-14 2010-09-29 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2010129947A2 (en) * 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
CN113855806A (zh) 2014-10-21 2021-12-31 赛生药品股份国际有限公司 用免疫刺激剂治疗癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate

Also Published As

Publication number Publication date
DK138891C (da) 1979-04-23
DK138891B (da) 1978-11-13
IL51316A0 (en) 1977-03-31
DK49077A (da) 1977-08-08
DE2604845A1 (de) 1977-08-18
PL105526B1 (pl) 1979-10-31
BE850492A (fr) 1977-07-18
AU2195277A (en) 1978-08-10
IE44339B1 (en) 1981-10-21
PT66154B (fr) 1978-07-07
SE7701187L (sv) 1977-08-08
FI770398A (sv) 1977-08-08
ES455691A1 (es) 1978-01-01
NO142625B (no) 1980-06-09
LU76706A1 (sv) 1977-06-28
IE44339L (en) 1977-08-07
FR2340311B1 (sv) 1980-02-08
AU504526B2 (en) 1979-10-18
CS201544B2 (en) 1980-11-28
GB1550545A (en) 1979-08-15
HU173483B (hu) 1979-05-28
JPS52105186A (en) 1977-09-03
US4079137A (en) 1978-03-14
FI63226B (fi) 1983-01-31
CA1094560A (en) 1981-01-27
NO770374L (no) 1977-08-09
ZA77248B (en) 1977-11-30
FR2340311A1 (fr) 1977-09-02
DD128133A5 (de) 1977-11-02
PT66154A (fr) 1977-03-01
ATA68177A (de) 1979-08-15
IL51316A (en) 1980-12-31
AT355578B (de) 1980-03-10
NL7700841A (nl) 1977-08-09
NO142625C (no) 1980-09-17
FI63226C (fi) 1983-05-10

Similar Documents

Publication Publication Date Title
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
DE2658544C2 (de) Carbostyrilderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2024001B2 (de) Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
CH615413A5 (en) Process for the preparation of novel 1-aminoalkyl-2-arylcyclohexanol compounds
DE1220440B (de) Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH631448A5 (de) Verfahren zur herstellung neuer piperazinderivate.
DE2702537A1 (de) Neue piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3025238C2 (sv)
EP0018360B1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1470194C3 (de) 1,3,3-trisubstituierte 4-0mega-(Aminoalkyl) -2-pyrrolidinone und-2-thiopyrrolidinone
EP0056486B1 (de) Phenylpiperazinyl-propanole von Hetarylphenolen, ihre Herstellung und diese enthaltende therapeutische Mittel
DE3305495A1 (de) Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
CH643821A5 (de) Substituierte phenylacetylguanidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE1921453B2 (de) Basische Dithienylderivate
DE1620342C3 (sv)
DE2735589A1 (de) 1-phenyl-1-methoxy-2-amino-aethan- derivate und verfahren zu ihrer herstellung
CH631982A5 (de) Verfahren zur herstellung neuer alkylendioxypiperazinderivate.
DE2508331A1 (de) 1-(3-phenylpropyl)-4-furoylpiperazine
DE1185615B (de) Verfahren zur Herstellung von 1, 4-disubstituierten Piperazinen
AT363092B (de) Verfahren zur herstellung von neuen piperazinderivaten und deren salzen
DE1545744C (de) Basische Terpenätherderivate
CH627458A5 (de) Verfahren zur herstellung neuer piperazinderivate.
DE2519163C2 (de) 2-Formyl-1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert.butyl-aminopropoxy)-isochinolin, dessen Salze, Verfahren zu deren Herstellung und ihre Verwendung

Legal Events

Date Code Title Description
PL Patent ceased